Intrinsic Value of S&P & Nasdaq Contact Us

Harrow Health, Inc. 8.625% Senior Notes due 2026 HROWL NASDAQ

NASDAQ Global Market • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score
39/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — HROWL

Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) has a market capitalization of $1.37B and trades at $25.61. The 52-week range is 25-25.72.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -182.9, Earnings Per Share (EPS) of $-0.14, annual revenue of $272.3M.

The stock has a beta of 0.14, a last dividend of $1.6172, operates in the Healthcare sector.

Trading Data
Current Price$25.61
52-Week Range25-25.72
Volume7.66K
Avg Volume (30D)16.25K
Market Cap$1.37B
Beta (1Y)0.14
Last Dividend$1.6172
Company
IPO Date2021-05-07
Employees217
CEOMark L. Baum
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS4158582084
Income (Latest Year)
Revenue$272.3M
Gross Profit$204.37M
EBITDA$56.08M
Operating Income$36.4M
Net Income$-5.14M
EPS$-0.14
EPS Diluted$-0.14
Shares Outstanding$36.76M
Balance Sheet (Latest Year)
Total Assets$399.48M
Current Assets$211.75M
Cash & ST Investments$72.93M
Total Liabilities$347.39M
Total Debt$251.98M
Net Debt$179.05M
Total Equity$52.09M
Debt / Equity4.84
Valuation Ratios
P/E Ratio-182.9
P/S Ratio5.02
P/B Ratio26.23
EV/EBITDA (approx)24.4
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message